Senior insider sale
Chief Medical Officer at REGENXBIO INC. — senior position signals high conviction
$421.4K
40.04K shares
What this filing means
PAKOLA STEVE plans to sell 40.04K shares of REGENXBIO INC. valued at approximately $421.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001950047-26-004334
Officer· Chief Medical Officer
Since Apr 2019
40.04K
Shares to sell
$421.4K
Approx. market value
34.92K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/1/2026
34.92KTotal acquired34.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2026 | Restricted Stock Units N/A | 34.92K | — |
| Total | 34.92K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.12K
Market value
$53.0K
3/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
34.92K
Market value
$368.4K
5/11/2026
Total
Units
40.04K
Value
$421.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 5.12K | $53.0K | — | Completed |
| Planned — Approximate Date | ||||
5/11/2026 | 34.92K | $368.4K | NASDAQ | Planned |
| Total | 40.04K | $421.4K | ||